Qualissima   Report issue

For profit Phase 1 Phase 4
Founded: Marseille France (2001)

Organization Overview

First Clinical Trial
2008
NCT01048229
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Qualissima

Active Ingredients

Drugs in Phase 4 Trials (2)

pramipexole (mirapex) (1 trial)

rasagiline (azilect) (1 trial)

Drugs in Phase 1 Trials (4)

donepezil (aricept) (1 trial)

ifb-088 (1 trial)

memantine (namenda) (1 trial)

modafinil (provigil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 4)

Sleep Deprivation (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6